Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT02494583.
Publications
View AllAffiliated Researchers
Institution Info
- Type
- healthcare
- Country
- CL
- Publications
- 1
- Citations
- 1,036
External Links
Identifiers
- ROR
- https://ror.org/02xtpdq88